Asterand enters accord with Abcam

Asterand, a UK-based provider of human tissue for R&D, has entered into a collaborative agreement with Abcam, a British bioscience company that  markets antibodies via its own on-line catalogue.

Asterand will undertake the validation and characterization of a  selected group of Abcam antibodies for immuno-histochemistry  applications using Asterand's PhaseZERO Human Tissue Services platform.

Through this agreement, Asterand will utilize its proprietary Target  Evaluator database to pinpoint the expression patterns of selected  antibody targets across a panel of human tissue types. The database  consists of quantitative human gene expression profiles that chart the  expression topography of more than 2,000 commercially-relevant gene  transcripts across a panel of 72 human tissues.